World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
25986
World Ranking
1319
National Ranking
26

Medicine

D-Index
86
Citations
26130
World Ranking
14170
National Ranking
263

Jan Andersson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jan Andersson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 280 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jan Andersson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Andersson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Internal medicine
  • Cytokine

Jan Andersson mainly investigates Immunology, Internal medicine, Cytotoxic T cell, Virology and Cytokine. Antigen, CD8, Immune system, Chemokine and Lymphocyte are among the areas of Immunology where the researcher is concentrating his efforts. His Internal medicine research incorporates elements of Gastroenterology and Surgery.

The various areas that Jan Andersson examines in his Cytotoxic T cell study include T cell and Peripheral blood mononuclear cell. His Virology research includes elements of Tumor necrosis factor alpha, Interleukin 12, Lymphatic system and Dendritic cell. Many of his research projects under Cytokine are closely connected to Connective tissue disease with Connective tissue disease, tying the diverse disciplines of science together.

His most cited work include:

  • Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis (477 citations)
  • Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial (413 citations)
  • Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock* (351 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Immunology, Cytokine, Immune system, Internal medicine and Antigen. His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Tuberculosis and Virology. His biological study spans a wide range of topics, including Cell, Superantigen, Chemokine, Peripheral blood mononuclear cell and Immunotherapy.

His Immune system research incorporates themes from Lymphatic system and In vivo. In general Internal medicine, his work in Transplantation is often linked to Placebo linking many areas of study. His studies in Antigen integrate themes in fields like Molecular biology, Antibody and CD40.

He most often published in these fields:

  • Immunology (64.29%)
  • Cytokine (25.21%)
  • Immune system (17.23%)

What were the highlights of his more recent work (between 2009-2021)?

  • Immunology (64.29%)
  • Tuberculosis (8.40%)
  • Immune system (17.23%)

In recent papers he was focusing on the following fields of study:

His main research concerns Immunology, Tuberculosis, Immune system, Mycobacterium tuberculosis and Positron emission tomography. His Immunology research is multidisciplinary, relying on both Disease and Virology. Jan Andersson interconnects vitamin D deficiency, Case-control study, Immunity and Vaccination in the investigation of issues within Tuberculosis.

His studies in Immune system integrate themes in fields like Myeloid and Pathogenesis. His study in Mycobacterium tuberculosis is interdisciplinary in nature, drawing from both Interleukin, Peripheral blood mononuclear cell, Antibody and Lymphocyte. His Positron emission tomography study combines topics from a wide range of disciplines, such as Pathology, Benzodiazepine and In vivo, Radioligand.

Between 2009 and 2021, his most popular works were:

  • Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection (246 citations)
  • Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. (115 citations)
  • Totally drug‐resistant tuberculosis and adjunct therapies (100 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Internal medicine
  • Gene

His primary areas of investigation include Immunology, Tuberculosis, Mycobacterium tuberculosis, Immune system and Virology. Immunology and Shigellosis are two areas of study in which Jan Andersson engages in interdisciplinary research. The various areas that he examines in his Tuberculosis study include Peripheral blood mononuclear cell and Cytokine.

His biological study spans a wide range of topics, including Chemokine, Bronchoalveolar lavage and CCL5. His Immune system study combines topics in areas such as Disease and Pathogenesis. Jan Andersson combines subjects such as Foreskin, Langerin and C-type lectin with his study of Virology.

Best Publications

  • HMG-1 as a Late Mediator of Endotoxin Lethality in Mice

    Haichao Wang;Ona Bloom;Minghuang Zhang;Jaideep M. Vishnubhakat

  • Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial

    Jessica Darenberg;Nahla Ihendyane;Jan Sjölin;Ewa Aufwerber

  • Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis

    Laura A. Napolitano;Robert M. Grant;Steven G. Deeks;Diane Schmidt

  • Selective induction of DNA synthesis in T and B lymphocytes

    Jan Andersson;Jan Andersson;Göran Möller;Göran Möller;Olof Sjöberg;Olof Sjöberg

  • Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*

    Jonas Sundén-Cullberg;Anna Norrby-Teglund;Ari Rouhiainen;Heikki Rauvala

  • Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients

    Jan Andersson;Adriano Boasso;Jakob Nilsson;Rui Zhang

  • HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

    Jakob Nilsson;Adriano Boasso;Paula Andrea Velilla;Rui Zhang

  • Ribavirin treatment for chronic hepatitis C.

    O. Reichard;J. Andersson;R. Schvarcz;O. Weiland

  • High mobility group 1 B‐box mediates activation of human endothelium

    C. J. Treutiger;G. E. Mullins;A.-S. M. Johansson;A. Rouhiainen;A. Rouhiainen

  • Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection

    Edwin Leeansyah;Anupama Ganesh;Máire F. Quigley;Anders Sönnerborg

  • Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.

    Rubhana Raqib;Protim Sarker;Peter Bergman;Gul Ara

  • Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.

    Judy Lieberman;Premlata Shankar;N. Manjunath;Jan Andersson

  • Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells

    Anna Smed-Sörensen;Karin Loré;Jayanand Vasudevan;Mark K. Louder

  • Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection

    Werner Henle;Gertrude Henle;Jan Andersson;Ingemar Ernberg

  • Repertoire of Chemokine Receptor Expression in the Female Genital Tract : Implications for Human Immunodeficiency Virus Transmission

    Bruce K. Patterson;Alan Landay;Jan Andersson;Clark Brown

  • Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study.

    Peter Bergman;Anna-Carin Norlin;Anna-Carin Norlin;Susanne Hansen;Rokeya Sultana Rekha

  • Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

    Jan Bakker;Robert Grover;Angela McLuckie;Laurent Holzapfel

  • Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.

    A K Ulfgren;S Lindblad;L Klareskog;J Andersson

  • Bacterial toxin-induced cytokine production studied at the single-cell level.

    Jan Andersson;Stephanie Nagy;Lars Bjourk;John Abrams

  • Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

    Ulf Andersson;Ulf Andersson;Lars Bjork;Ulrika Skansen-Saphir;Ulrika Skansen-Saphir;Jan Andersson;Jan Andersson

Frequent Co-Authors

Christer Halldin
Christer Halldin Karolinska Institute
Rubhana Raqib
Rubhana Raqib International Centre for Diarrhoeal Disease Research
Ulf Andersson
Ulf Andersson Karolinska University Hospital
Lars Farde
Lars Farde Karolinska Institute
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
Karin Loré
Karin Loré Karolinska Institute
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Anna Norrby-Teglund
Anna Norrby-Teglund Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career avenues. Many professionals transition into nursing specializations that closely align with immunological research and patient care. Exploring the highest paid dnp specialties can help guide your decision towards roles that reward advanced expertise and specialization.

If you're a Family Nurse Practitioner (FNP) aiming to focus on critical care, understanding the acute care np certification is essential. This certification prepares nurses to work with patients needing intensive immunological interventions, expanding job prospects.

For accelerated career advancement, many seek the accelerated nurse practitioner programs that offer flexible online formats. These programs cater to motivated individuals wanting to fast-track their expertise in immunology-related healthcare fields.

Beginners without a nursing background can also find suitable education paths. The best online rn programs for non nurses provide a foundation to enter nursing with an emphasis on immunology topics, promoting a smooth career entry.

Best Scientists Citing Jan Andersson

Trending Scientists

Recently Published Articles